CYCC - Cyclacel Pharmaceuticals EPS beats by $0.04 November, 13 2019 04:09 PM Cyclacel Pharmaceuticals Inc. Cyclacel Pharmaceuticals (NASDAQ:CYCC): Q3 GAAP EPS of -$0.11 beats by $0.04.Cash and cash equivalents of $12.96MPress ReleaseMore news on: Cyclacel Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, ,